BRG Borregaard

Borregaard ASA: EBITDA1 of NOK 327 million in the 4th quarter

Borregaard ASA: EBITDA1 of NOK 327 million in the 4th quarter

Borregaard’s operating revenues were NOK 1,605 million (NOK 1,770 million)2 in the 4th quarter of 2023. EBITDA1 was NOK 327 million (NOK 364 million). The result in BioSolutions improved while BioMaterials’ and Fine Chemicals’ results were lower compared with the 4th quarter of 2022. Operational issues at the Sarpsborg site and lower demand for and sales of biovanillin had a negative impact in the 4th quarter of approximately NOK 80 million.

In BioSolutions, reduced energy costs were partly offset by reduced sales volume and cost inflation in general. The reduced result in BioMaterials was mainly due to the operational issues at the Sarpsborg site. In Fine Chemicals, lower production volume and lower sales prices in fine chemical intermediates had a negative impact on EBITDA1 compared with the 4th quarter of 2022. The net currency effects were positive for the Group.

Profit before tax was NOK 135 million (NOK 210 million). Earnings per share were NOK 1.20 (NOK 1.85).

Full year 2023

Operating revenues increased to NOK 7,132 million (NOK 6,881 million). EBITDA1 reached an all-time high of NOK 1,781 million (NOK 1,643 million). Profit before tax was NOK 1,124 million (NOK 1,118 million). Earnings per share were NOK 8.73 (NOK 8.95).

- We are pleased to deliver an all-time high result in a year with challenging macroeconomic conditions, says President and CEO Per A. Sørlie.

Contacts:

Director Investor Relations, Knut-Harald Bakke, +47 905 79 164

Director Communications, Tone Horvei Bredal, +47 924 67 711

1. Operating profit before depreciation, amortisation and other income and expenses

2. Figures in parentheses are for the corresponding period in the preceding year

This information is considered to be inside information pursuant to the EU Market Abuse Regulation and is subject to the disclosure requirements pursuant to Section 5 – 12 of the Norwegian Securities Trading Act.

This stock exchange announcement was published by Lotte Kvinlaug, Investor Relations Officer at Borregaard ASA, on 31 January 2024 at 07:00 CET.

 

Attachments



EN
31/01/2024

Underlying

BRGBorregaard

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Borregaard

ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Henrik Bartnes
  • Martin Melbye
UPM UPM-KYMMENE OYJ
SCA B SVENSKA CELLULOSA AKTIEBOLAGET CLASS B
STERV STORA ENSO OYJ CLASS R
HUH1V HUHTAMAKI OYJ
METSB METSA BOARD OYJ CLASS B
BILL BILLERUDKORSNAS AB
BRG BORREGAARD
ESSITY B ESSITY AB CLASS B
HOLM B HOLMEN AB CLASS B
NPAPER NORDIC PAPER HOLDING
ELO ELOPAK ASA
NSKOG NORSKE SKOG ASA
05/15/25 May 15, 2025 1 EN
Niclas Gehin
  • Niclas Gehin
Free Trial
BRG BORREGAARD

Borregaard (Buy, TP: NOK230.00) - Agricultural products boost Q1 EPS

The solid Q1 results included a 6% EBITDA beat, led by record-high sales and profits from growing agricultural product sales – management said the underlying trend was driven by demand for ‘green’ food production products. Our 2026–2027e EPS are largely unchanged (tweaked by c1%) as the USD depreciation and lowered bioethanol price guidance largely offset the higher agricultural product sales. We still see this as an attractive entry point, and reiterate our BUY and NOK230 target price.

04/30/25 April 30, 2025 1 EN
ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Henrik Bartnes
  • Martin Melbye
04/30/25 April 30, 2025 1 EN
ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Ali Shemmari
  • Martin Melbye
04/30/25 April 30, 2025 1 EN
 PRESS RELEASE
Free
BRG BORREGAARD

Borregaard ASA: EBITDA1 of NOK 511 million in the 1st quarter

Borregaard ASA: EBITDA1 of NOK 511 million in the 1st quarter Borregaard’s operating revenues increased to NOK 2,036 million (NOK 1,975 million)2 in the 1st quarter of 2025. EBITDA1 reached NOK 511 million (NOK 442 million). The result in BioSolutions increased, BioMaterials had a result in line with the corresponding quarter last year and Fine Chemicals had a lower result. Strong sales to agriculture were the main reason for the all-time high result in BioSolutions. For BioMaterials, higher sales prices were offset by lower sales volume, increased wood costs, and cost increases in general...

April 30, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch